These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36062451)

  • 21. Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM-HF2 trial.
    Stegmann T; Koehler K; Wachter R; Moeller V; Zeynalova S; Koehler F; Laufs U
    ESC Heart Fail; 2020 Oct; 7(5):2516-2526. PubMed ID: 32558287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Telemedicine in heart failure].
    Köhler F; Prescher S; Köhler K
    Internist (Berl); 2019 Apr; 60(4):331-338. PubMed ID: 30820589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Will telemonitoring be adopted by patients with chronic heart failure?].
    Prescher S; Deckwart O; Koehler K; Lücke S; Schieber M; Wellge B; Winkler S; Baumann G; Koehler F
    Dtsch Med Wochenschr; 2014 Apr; 139(16):829-34. PubMed ID: 24722932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of home telemonitoring to support multidisciplinary care of heart failure patients in Finland: randomized controlled trial.
    Vuorinen AL; Leppänen J; Kaijanranta H; Kulju M; Heliö T; van Gils M; Lähteenmäki J
    J Med Internet Res; 2014 Dec; 16(12):e282. PubMed ID: 25498992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial.
    Felker GM; Solomon SD; Claggett B; Diaz R; McMurray JJV; Metra M; Anand I; Crespo-Leiro MG; Dahlström U; Goncalvesova E; Howlett JG; MacDonald P; Parkhomenko A; Tomcsányi J; Abbasi SA; Heitner SB; Hucko T; Kupfer S; Malik FI; Teerlink JR
    JAMA Cardiol; 2022 Jan; 7(1):26-34. PubMed ID: 34643642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
    Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B; Drazner MH; Fong MW; Givertz MM; Gordon RA; Jermyn R; Katz SD; Lamba S; Lanfear DE; LaRue SJ; Lindenfeld J; Malone M; Margulies K; Mentz RJ; Mutharasan RK; Pursley M; Umpierrez G; Kosiborod M
    Circulation; 2019 Oct; 140(18):1463-1476. PubMed ID: 31524498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home monitoring with IT-supported specialist management versus home monitoring alone in patients with heart failure: Design and baseline results of the SUPPORT-HF 2 randomized trial.
    SUPPORT-HF 2 Investigators and Committees. Electronic address: kazem.rahimi@georgeinstitute.ox.ac.uk
    Am Heart J; 2019 Feb; 208():55-64. PubMed ID: 30553130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HEART Camp Exercise Intervention Improves Exercise Adherence, Physical Function, and Patient-Reported Outcomes in Adults With Preserved Ejection Fraction Heart Failure.
    Alonso WW; Kupzyk KA; Norman JF; Lundgren SW; Fisher A; Lindsey ML; Keteyian SJ; Pozehl BJ
    J Card Fail; 2022 Mar; 28(3):431-442. PubMed ID: 34534664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
    Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
    JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure.
    Clark AL; Johnson M; Fairhurst C; Torgerson D; Cockayne S; Rodgers S; Griffin S; Allgar V; Jones L; Nabb S; Harvey I; Squire I; Murphy J; Greenstone M
    Health Technol Assess; 2015 Sep; 19(75):1-120. PubMed ID: 26393373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the user experience of televisits and telemonitoring for heart failure patients in less than 6 months: a methodological approach.
    Savoldelli A; Vitali A; Remuzzi A; Giudici V
    Int J Med Inform; 2022 May; 161():104717. PubMed ID: 35259670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Schöpe J; Wagenpfeil S; Tavazzi L; Böhm M; Ponikowski P; Anker SD; Filippatos GS; Cowie MR;
    Eur J Heart Fail; 2019 Jul; 21(7):921-929. PubMed ID: 30933403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study.
    Dendale P; De Keulenaer G; Troisfontaines P; Weytjens C; Mullens W; Elegeert I; Ector B; Houbrechts M; Willekens K; Hansen D
    Eur J Heart Fail; 2012 Mar; 14(3):333-40. PubMed ID: 22045925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
    JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of multifaceted optimization management for chronic heart failure: a multicentre, randomized controlled study.
    Pan G; Ji W; Wang X; Li S; Zheng C; Lyu W; Feng X; Xia Y; Xiong Z; Shan H; Yang H; Zou X
    ESC Heart Fail; 2023 Feb; 10(1):133-147. PubMed ID: 36178015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of telemedicine on the clinical outcomes and healthcare costs of patients with chronic heart failure and mid-range or preserved ejection fraction managed in a multidisciplinary chronic heart failure programme: A sub-analysis of the iCOR randomized trial.
    Jiménez-Marrero S; Yun S; Cainzos-Achirica M; Enjuanes C; Garay A; Farre N; Verdú JM; Linas A; Ruiz P; Hidalgo E; Calero E; Comín-Colet J
    J Telemed Telecare; 2020; 26(1-2):64-72. PubMed ID: 30193564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Hospital-Community-Family-Based Telehealth Program for Patients With Chronic Heart Failure: Single-Arm, Prospective Feasibility Study.
    Guo X; Gu X; Jiang J; Li H; Duan R; Zhang Y; Sun L; Bao Z; Shen J; Chen F
    JMIR Mhealth Uhealth; 2019 Dec; 7(12):e13229. PubMed ID: 31833835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-device-based telemonitoring : Toy or tool?].
    Stockburger M
    Herzschrittmacherther Elektrophysiol; 2017 Sep; 28(3):287-292. PubMed ID: 28831544
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.